Drug Description in Trials / DrugBank / KEGG DRUG


Search results


No. DrugBank Drug (Description in trials) KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
1 Caplacizumab
(caplacizumab-yhdp)
[1] CAPLACIZUMAB[1] Caplacizumab (Caplacizumab, Caplacizumab-yhdp) 💬 [1] VWF 💬 [9] Complement and coagulation cascades, Coronavirus disease, ECM-receptor interaction, Focal adhesion, Human papillomavirus infection, Integrin signaling, Neutrophil extracellular trap formation, PI3K-Akt signaling pathway, Platelet activation 💬[2] 63, 64 💬